Rob advises listed companies and large private companies on their key corporate transactions, whether M&A, fundraising or strategic planning.

Rob's experience

  • Advised the Huntsworth Group, an international healthcare and communications specialist, on all aspects of the acquisition of the Nucleus Communications Group. The Nucleus Communications Group is the largest specialist medical communications network in the world and was founded in London by Dr Stephen Cameron in 1986.

  • Advised Forterra PLC, a producer and provider of masonry products, on a successful accelerated bookbuild placing of new ordinary shares, raising £55 million.

  • Advised Robert Bosch Investment Nederland BV, a member of the Robert Bosch GmbH group, on a further investment in Ceres Power Holdings plc., a world-leading developer of next generation solid oxide fuel cell technology. Bosch has increased its stake in Ceres Power from c. 4% to 17.8% through a purchase of shares in the secondary market from existing shareholders and a subscription for new shares.

  • Advised an investments partnership on a placing undertaken by way of accelerated bookbuild in main market listed company Motorpoint Group plc, which raised aggregate gross proceeds of £22 million.

  • Advised Premier Technical Services Group plc on its recommended acquisition by an entity set up by the Australian investment group Macquarie.

  • Advised Hunstworth, a healthcare and communications company, on a £16.3 million Placing to part fund 2 acquisitions: Creativ-Ceutical SARL, a strategic market access, health economics and outcomes research consultancy, for an initial cash consideration of €15.5 million and Kyne, a health communications agency providing public relations and patient advocacy services, for an initial cash consideration of US$17.4 million.

  • Advised CommScope, a Nasdaq listed technology company and leader in the field of communication and network infrastructures, on an ambitious, transatlantic deal to acquire the Nasdaq listed company ARRIS International plc for $7.4 billion. The transaction was structured by way of an English law scheme of arrangement and was subject to approval by the shareholders of ARRIS and included complex tax matters.

  • Advised Huntsworth, an international healthcare and communications group, on the recommended cash acquisition of Huntsworth by Clayton, Dubilier & Rice, LLP. The cash consideration values the current issued share capital at c. £400 million and implies an enterprise value of £524 million.

  • Acted for DCC plc on its £600million accelerated fundraising

    • United Kingdom
  • Advising Huntsworth Plc, a healthcare and communications company, on its a £18m institutional placing to fund its acquisition of Navience Healthcare Solutions LLC.

Credentials

  • 2002
    Joined Pinsent Masons
  • 1998
    Senior Associate - Freshfields Bruckhaus Deringer
  • 1994
    Qualified - England and Wales
  • 1992
    Solicitor - Stephenson Harwood
Load More

Out-Law / Insight by Rob Hutchings

We are processing your request. \n Thank you for your patience. An error occurred. This could be due to inactivity on the page - please try again.